Press Releases

GlobeNewswire, Inc.

– Phase 3 results highlight benefits of ATEV for patients at higher risk of fistula failure, including all women and men with obesity and diabetes – – Publication provides peer-reviewed validation for V007 Phase 3 data, and complements recent...

Massachusetts Cannabis Control Commission

The audit tested the accuracy of THC potency on flower product labels WORCESTER—As part of its ongoing shelf audit program, the Massachusetts Cannabis Control Commission (Commission) recently completed a review of THC potency on cannabis flower...

GlobeNewswire, Inc.

CANTON, Mass., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, announced today it will release its second quarter of fiscal 2026...

EIN Presswire

BOSTON, MA, UNITED STATES, August 14, 2026 /⁨EINPresswire.com⁩/ -- Western Specialty Contractors’ NYC Metro branch has completed a waterproofing project at an office building in Boston, MA. Serving as the prime contractor, Western recaulked the...

GlobeNewswire, Inc.

Announced recent Investigational New Drug (IND) submission to the FDA for CUE-221 in food allergy applications Completed a $50 million private placement (PIPE) to further fund clinical development and the portfolio with significant potential for...

City of Boston

Mayor Michelle Wu announced Shin-pei Tsay as Chief Information Officer for the Department of Innovation and Technology (DoIT), a key senior role focused on strengthening City’s digital infrastructure and service delivery across neighborhoods....

GlobeNewswire, Inc.

Successful End-of-Phase 2 meeting with FDA supports advancement of tegoprubart into a global Phase 3 kidney transplantation trial, on track to initiate in late 2026 Long-term Phase 2 BESTOW data presented at ATC 2026 demonstrated sustained higher...

GlobeNewswire, Inc.

Reported positive results from the potentially registrational Phase 2 ZEPHYR trial of ML-007C-MA in schizophrenia, supporting advancement into a Phase 3 ZEPHYR-2 trial Continued advancement of ML-007C-MA in ADP, with enrollment ongoing in the...

GlobeNewswire, Inc.

Presented first-in-human clinical imaging and dosimetry data for AKY-2519, supporting a broad clinical development program in patients with prostate, lung, and other B7-H3 expressing solid tumors Enrolling patients in Phase 1b trial of AKY-1189 in...

GlobeNewswire, Inc.

AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Vereigen Media, a global leader in B2B demand generation and zero outsourcing data intelligence, today announced that registration for its upcoming premier networking event, ‘Boston Marketers...

GlobeNewswire, Inc.

DALLAS, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Fogo de Chão, the internationally renowned restaurant founded in Brazil over 46 years ago and known for its elevated churrasco dining experience, today announced the signing of a lease agreement at...

The Florida Bar

Aug 10, 2026 Gov. Ron DeSantis announced 13 judicial appointments in July. Thomas Rebull of Miami to served as a judge on the Third District Court of Appeal.

GlobeNewswire, Inc.

Company announcement – No. 38 / 2026 Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Zealand Pharma will receive USD 100 million for the sale of its...

GlobeNewswire, Inc.

BOSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Rapid7 (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, today released new research conducted by Omdia, a division of TechTarget, Inc., revealing that while AI has earned...

EIN Presswire

New badge gives software and SaaS companies a faster way to identify a HubSpot partner that already knows their business.

GlobeNewswire, Inc.

AUSTIN, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Vereigen Media, a B2B demand generation company built on human-verified engagement and first-party data intelligence, today announced its inclusion on the 2026 Inc. 5000 list of America's...

GlobeNewswire, Inc.

Phase 3 C-BEYOND Trial Met Primary and Secondary Endpoints, with a Short 8-week Duration for Patients Without Cirrhosis Supporting a Potential Best-in-Class Profile of BEM/RZR for Treatment of HCV C-FORWARD Phase 3 Trial Outside North America on...

GlobeNewswire, Inc.

Completed enrollment of MIST global Phase 2b trial of AP01 with 398 patients; topline data expected in the second half of 2027 Two abstracts accepted for presentation at the European Respiratory Society (ERS) Congress, including data modeling AP01...

GlobeNewswire, Inc.

Topline data from CHAPTER-3, a pivotal Phase 3 study of deucrictibant XR for the prophylaxis of HAE attacks, expected in 3Q2026 Deucrictibant IR NDA under review by the FDA with PDUFA date of April 23, 2027; MAA validated by the EMA in July 2026...

GlobeNewswire, Inc.

– Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with the Food and Drug Administration (FDA) during...